- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT01174316
Autotitrating Versus Standard Non-invasive Ventilation (NIV) in Acute Exacerbation of Respiratory Failure
Autotitrating Non-invasive Ventilation (NIV) Versus Standard NIV; a Randomised Crossover Trial in Patients With Acute Exacerbation of Chronic Respiratory Failure
The aim of the study is to compare the efficacy and tolerance of autotitrating non-invasive ventilation (NIV) versus standard NIV in patients admitted to hospital with acute exacerbation of chronic respiratory failure.
The investigators hypothesise that autotitrating NIV will ventilate patients with acute exacerbations of chronic respiratory failure as effectively as standard NIV.
Studieoversikt
Status
Forhold
Intervensjon / Behandling
Detaljert beskrivelse
The aim of the study is to compare the effect of two types of noninvasive ventilator (a small machine that assists breathing) in patients admitted to hospital with a sudden worsening of their existing breathing insufficiency, including an increase of carbon dioxide in the blood (hypercapnia) and acidity of the blood. Noninvasive ventilation (NIV) is standard therapy for patients with acute hypercapnic exacerbations (sudden worsening of existing breathing insufficiency) of both chronic obstructive pulmonary disease (COPD) and nonCOPD patients.
The most common type of NIV is bilevel pressure support which assists patient breathing by delivering different levels of air pressure during inspiration and expiration via a mask covering the nose or nose and mouth. Standard bilevel NIV (VPAP™) has been further developed to create a new automatically adjusting NIV (AutoVPAP™). Automatically adjusting NIV varies the inspiratory air pressure according to the airflow rates generated by the patient. This may improve patient comfort, hours of NIV use and recovery time.
Patients over the age of 18 admitted to Royal Brompton Hospital respiratory ward will be considered for entry into this randomised crossover study. If eligible for inclusion and willing to take part patients will be setup on automatically adjusting NIV or standard NIV, assigned in random order. After 24 hours on the first NIV the patient will be swapped to the alternative NIV for a further 24 hours of treatment.
Studietype
Fase
- Ikke aktuelt
Kontakter og plasseringer
Studiesteder
-
-
-
London, Storbritannia, SW3 6NP
- Royal Brompton Hospital
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Beskrivelse
Inclusion Criteria:
- patients admitted or transferred to Royal Brompton Hospital with acute exacerbation of chronic respiratory failure, or inpatients who suffer a deterioration in respiratory status, defined as 7.25 < pH < 7.35, PaCO2 > 6.0kPa, and respiratory rate > 20bpm
Exclusion Criteria:
- < 18 years old
- pH < 7.25
- need for immediate intubation
- uncontrolled cardiac failure
- hypotensive (systolic blood pressure < 90mmHg)
- acute myocardial infarction
- acute dysrhythmia
- other system failure (e.g. acute renal failure, liver failure)
- moderate or severe bulbar weakness
- inability to understand rationale and/or consent form for study
Studieplan
Hvordan er studiet utformet?
Designdetaljer
- Primært formål: Behandling
- Tildeling: Randomisert
- Intervensjonsmodell: Crossover-oppdrag
- Masking: Enkelt
Våpen og intervensjoner
Deltakergruppe / Arm |
Intervensjon / Behandling |
|---|---|
|
Eksperimentell: autotitrating NIV
approximately 24 hours using autotitrating non-invasive ventilation for as many hours as possible whilst an inpatient in hospital
|
Automatically titrated non-invasive ventilator, with target gross alveolar ventilation, end expiratory positive pressure, and back up respiratory rate determined by the clinician based on height and weight.
The NIV must be used for as many hours as possible over the 24 hour period but breaks for meals, physiotherapy and bathroom are allowed.
Andre navn:
|
|
Aktiv komparator: Standard non-invasive ventilation
approximately 24 hours using standard non-invasive ventilation for as many hours as possible whilst an inpatient in hospital.
|
Standard non-invasive ventilator, with inspiratory and expiratory positive pressure determined by the healthcare professional.
The NIV must be used for as many hours as possible over the 24 hour period but breaks for meals, physiotherapy and bathroom are allowed.
Andre navn:
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
pH at 1+ hour
Tidsramme: 1 hour
|
pH of arterial blood after 1 hour of treatment with non-invasive ventialtion compared baseline value
|
1 hour
|
Sekundære resultatmål
Resultatmål |
Tiltaksbeskrivelse |
Tidsramme |
|---|---|---|
|
pH at 4+ hours
Tidsramme: 4+ hours of NIV treatment
|
pH of arterial blood after 4 hours of treatment with non-invasive ventialtion compared to baseline value
|
4+ hours of NIV treatment
|
|
Respiratory Rate at 1+ hour
Tidsramme: 1+ hour of NIV treatment
|
Respiratory rate after 1 hour of treatment with non-invasive ventilation compared to baseline value
|
1+ hour of NIV treatment
|
|
Respiratory rate at 4+ hours
Tidsramme: 4+ hours of NIV treatment
|
Respiratory rate after 4 hours of treatment with non-invasive ventilation compared to baseline value
|
4+ hours of NIV treatment
|
|
overnight mean transcutaneous carbon dioxide
Tidsramme: 24 hours
|
mean overnight transcutaneous carbon dioxide during sleep period
|
24 hours
|
|
PaCO2 at 1+ hours
Tidsramme: 1+ hours of NIV treatment
|
Carbon dixoide level of arterial blood after 1 hour of treatment with non-invasive ventilation compared to baseline
|
1+ hours of NIV treatment
|
|
PaCO2 at 4+ hours
Tidsramme: 4+ hours of NIV treatment
|
Carbon dioxide level in arterial blood after 4 hours of treatment with non-invasive ventilation compared to baseline value
|
4+ hours of NIV treatment
|
|
PaO2 at 1+ hour
Tidsramme: 1+ hour of NIV treatment
|
Oxygen level in arterial blood after 1 hour of treatment with non-invasive ventilation compared to baseline value
|
1+ hour of NIV treatment
|
|
PaO2 at 4+ hours
Tidsramme: 4+ hours of NIV treatment
|
Oxygen level in arterial blood after 4+ hours of treatment with non-invasive ventilation compared to baseline value
|
4+ hours of NIV treatment
|
Samarbeidspartnere og etterforskere
Sponsor
Samarbeidspartnere
Studierekorddatoer
Studer hoveddatoer
Studiestart (Faktiske)
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
- Sykdommer i nervesystemet
- Sykdommer i luftveiene
- Apné
- Respirasjonsforstyrrelser
- Søvnforstyrrelser, iboende
- Dyssomnier
- Søvnvåkenforstyrrelser
- Lungesykdommer
- Overernæring
- Ernæringsforstyrrelser
- Tegn og symptomer, luftveier
- Søvnapné syndromer
- Overvekt
- Søvnapné, obstruktiv
- Lungesykdommer, obstruktiv
- Lungesykdom, kronisk obstruktiv
- Respiratorisk insuffisiens
- Hypoventilasjon
- Fedme Hypoventilasjonssyndrom
- Nevromuskulære sykdommer
Andre studie-ID-numre
- 10/H0808/56
- R&D No. 2010LF008B (Annen identifikator: Research & Development Department, RBH)
- CI/2010/0027 (Annen identifikator: Medicines & Healthcare Products Regularoty Agency (devices))
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .